MUC1 and non-small cell lung carcinoma: Other liposomal drug formulations include, SPI-077 (liposomal cisplatin for solid tumors), CPX-351 (cytarabine: daunorubicin for acute myeloid leukemia), Lipoplatin (cisplatin for non-small cell lung cancer), ThermoDox (a thermosensitive doxorubicin for hepatocellular carcinoma, and other advanced cancers), and Stimulax (an anti-MUC1 cancer vaccine for non-small cell lung cancer).